Established in 2011, Singapore O&G Ltd. (SOG) is a leading healthcare service provider dedicated towards delivering premier medical services to women’s and children’s health and wellness at affordable prices.
With a long and established track record in Singapore providing obstetrics and gynaecology (O&G) services such as pre-pregnancy counselling, delivery, pregnancy and post-delivery care, the Group has since further expanded its spectrum of healthcare services to include paediatrics, endocrinology, gynaecological cancer, cancer-related general surgery for breast, thyroid and colon (colorectal), as well as skin and aesthetics treatments.
The Group’s clinics, under its four operating segments of O&G, Paediatrics, Cancer-related and Dermatology, are strategically located throughout Singapore to provide easy access to its patients.
SOG has been listed in the Catalist board of the Singapore Exchange Securities Trading Limited since 4 June 2015.
To bring new life, health and wellness to our patients and their families through the provision of excellent healthcare.
To be the premier specialist provider in holistic healthcare for women and children.
To be the preferred choice for patients seeking private specialist healthcare.
Accountability. We are responsible for our actions and attitudes.
Commitment to Excellence. We are committed to do our best for the care of our patients and their families.
Integrity. We are open, honest and ethical.
Respect. We embrace diversity and treat one another with dignity and empathy.
Teamwork. We work together in delivering the best medical outcomes and the highest quality of service.
The Board believes that diversity is for strong current and future business performance.
The Board diversity policy aims to set out the approach to achieve diversity, in the first instance, on the Board of Directors (the “Board”) of Singapore O&G Ltd. (the “Company”) and in the second instance amongst the Specialist Medical Practitioners and senior management of the Company.
This policy aims to set out the approach to achieve continued strong current and future business performance by promoting diversity on the Board and later, amongst the Specialist Medical Practitioners and management, of the Company.
To achieve strong current and future business performance, the Board shall execute, but not limited, to the following:
In the execution of the above, the Company shall:
The Board has established the following measurable objectives for workforce diversity in 2017:
|To have women on the Board.||Three (3) of our Directors are women.|
|To have women on board our senior management.||There is a senior management member who is a woman.|
|Due to the nature of the healthcare industry, we have more female than male employees. Where possible, recruit more male employees for our business.||As at 31 December 2020, the Group has a total of 80 employees (including Specialist Medical Practitioners); comprising 73 female and seven (7) male employees.|
The Board will assess the objectives annually, as well as the progress in achieving them.
Selection of new candidates across all levels will be based on different criteria, including but not limited to gender, age, cultural and educational background, professional and business experience, skills, knowledge, functional expertise and competencies.
The outcome of our selection process for the Board members will be based on merit and contribution that the selected candidate will bring to the Board. The Board’s composition will be disclosed in our Corporate Governance Report on an annual basis.
The Nomination Committee reviews and monitors the implementation of this policy. The Company will report the employee’s and Board’s composition with details in the Annual Report on an annual basis.
The Nomination Committee will review this policy to ensure its appropriateness and effectiveness. The Nomination Committee will discuss any revisions that may be required, and will subsequently recommend any such revisions to the Board for consideration and approval.
This policy will be published on the Company’s website for stakeholder’s information.
The Board of Directors (the “Board”) of Singapore O&G Ltd. (the “Company”) and its subsidiaries (together with the Company, the “Group”) seeks to conduct its business in an ethical manner and in compliance with best practice.
As a result, we have developed a Code of Ethics that we expect to continue to refine with various stakeholders. The underlying principle of the Code of Ethics is that we expect our management and staff to act with integrity towards those with whom we have business dealings, to the people in the society where we do business and towards each other. The Code of Ethics is over and above the Code of Medical Ethics and is designed to cover areas not covered by the Code of Medical Ethics and especially in the business and finance dealings of the Group. The Code of Ethics outlines how this principle is to be applied.
Our systems and processes are based on:
In the exercise of their ownership rights, shareholders shall:
In the exercise of their respective functions, they should:
In relation to Management functions to:
By age, disability, features, genetic, nationality, pregnancy, race, religion, sex or sexual preference.
Singapore O&G Ltd. (“SOG”) and its subsidiaries (collectively, the “Group”) is committed to maintaining high standards of honesty, openness and accountability.
The Group has adopted a Whistleblowing Policy and the following sets out the policy and procedures by which you can report your concerns. The Whistleblower can be assured that the information will be examined carefully and if it has merit will be acted on. The whistleblower (internal and external) can be assured that the Group intends to protect its business and reputation.
SOG takes all malpractice very seriously, whether it is committed by an employee, supplier customer, competitor or contractor.
This Policy Statement applies to all employees, agents and consultants. It is intended to complement statutory protection and, for the avoidance of doubt, statutory rights will not be affected in any way by this policy.
The following examples demonstrate what we mean by serious malpractice:
If you become aware of any such activities or other possible malpractices, you are encouraged to follow the procedures set out below. It will not always be clear that a particular action falls within one of these categories, and you will need to use your own judgment. However, if you believe the matter to be serious, SOG would prefer you to report your concerns rather than keep them to yourself.
You can make a report orally or in writing. Normally, for employees, you should inform your immediate manager, or their line manager.
Historically, a direct whistleblowing channel through email has been implemented to enable our stakeholders to get direct access to our Audit Committee Chairman. With effect from February 2018, the Company has assessed the need to have more than one whistleblowing channels and our stakeholders can now use any of the following whistleblowing channels:
Go first to the Audit Committee Chairman who is an independent non-executive director and who can hire lawyers, if required.
SOG does not expect you to have absolute proof of any malpractice that you report. However, you will need to be able to explain the reasons for your concern. Whilst the Group wishes to encourage whistleblowing, it will not tolerate spurious or vindictive allegations.
Once you have made a report, the Audit Committee Chairman or an unrelated (to the incident or person being reported) SOG senior management will acknowledge receipt of it within 10 working days.
An independent person will then make preliminary enquiries as confidentially as possible. If the person raising the concern is required to attend face-to-face meeting, a fellow employee may accompany him or her where appropriate.
If it is determined that a fuller investigation is necessary, this will proceed either with further internal investigations, or by referral to an appropriate external body, dependent upon the nature and the seriousness of the report.
If you make a report, SOG will do everything possible to keep your identity as confidential as possible during the investigation and you may assume that only the SOG person investigating the malpractice concern will know your identity. However, there may be circumstances (for example, if your report becomes the subject of a criminal investigation) where you may be needed as a witness and, once the investigation is complete, the findings may need to be communicated to the individual(s) concerned (see below). Should this be the case we will discuss the matter with you at the earliest opportunity.
The Group would prefer you to give your name and contact details when you make a report. However, you are also allowed to communicate your concern on a confidential basis.
Subject to any legal constraints, SOG will communicate the findings of the investigation to:
You as the person raising the report;
The individual(s) under investigation; and
If appropriate, SOG senior management or external authorities who need to consider whether action should be taken on the basis of the findings.
As with any case where an employee is found to be involved in wrongdoing, they will be dealt with effectively in accordance with employment laws and contracts of employment.
You can be assured that, if you raise an important concern, this will be taken seriously and you will be treated fairly and with discretion. We will take all reasonable steps to ensure that no person under our control engages in victimisation of any form. If you make a report in good faith, even if it is not confirmed by an investigation, your concern will be valued and appreciated and you will not be liable to disciplinary action. However, if you make a false report, maliciously or for personal gain, then you may face disciplinary action.
If you are unhappy with the outcome of an investigation, you should submit another report explaining why this is the case to the whole of the Board of Directors. Your concern will be investigated again if there is a good reason to do so.
If you are still unsatisfied with the result, you may make a report to the Singapore Stock Exchange or any other Singapore authorities you wish.